Filter by: patients
What is Atazanavir?

Atazanavir is a protease inhibitor used in the treatment of HIV-1 infections in combination with at least two other antiretroviral agents. In patients with prior virologic failure, coadministration with ritonavir is recommended.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 141 43 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Other 4 1 Efficacy_major
General health 4 1 Efficacy_moderate
Support immune health 2 1 Efficacy_major
Fatigue 1 0
Don't know 1 0

See all 152 patients currently taking Atazanavir

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
2
Moderate
14
Mild
9
None
21

Reported Dosages

Frequently reported dosages based on patients currently taking Atazanavir. See all 11 dosages

  daily 1 daily 2 tbs. daily 100 mg one time 100 mg daily 150 mg daily 200 mg daily 300 mg daily 400 mg daily 600 mg daily
  7 Number of Patients: 7 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 21 Number of Patients: 21 6 Number of Patients: 6 9 Number of Patients: 9 83 Number of Patients: 83 19 Number of Patients: 19 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Atazanavir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 15   Doctor's advice: 34%
Side effects too severe 14   Side effects too severe: 32%
Other 10   Other: 23%
Course of treatment ended 1   Course of treatment ended: 2%
Did not seem to work 1   Did not seem to work: 2%
Not indicated 1   Not indicated: 2%
Expense 1   Expense: 2%
Personal research 1   Personal research: 2%

See all 40 patients who’ve stopped taking Atazanavir

Currently Taking Atazanavir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Atazanavir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Atazanavir

Always
37 80%
Usually
6 13%
Sometimes
3 7%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Atazanavir

Very
0 0%
Somewhat
2 4%
A little
10 22%
Not at all
34 74%

Cost

Paid out of pocket

Cost of Atazanavir

$200+
0 0%
$100-199
0 0%
$50-99
4 14%
$25-49
6 21%
< $25
18 64%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 09, 2012.